Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/21/2022 | $62.00 → $49.00 | Overweight → Neutral | Piper Sandler |
| 3/28/2022 | $80.00 → $54.00 | Outperform → Neutral | Wedbush |
| 2/24/2022 | $80.00 → $65.00 | Neutral | UBS |
| 2/4/2022 | $85.00 → $88.00 | Neutral → Outperform | Wedbush |
GEM HEALTH's flagship product GEM SLEEP is now accessible through Sleep Number Corporation's new BreatheIQ™ digital sleep health app, providing a seamless connection point for users. MINNEAPOLIS, March 25, 2025 /PRNewswire/ -- Gem Specialty Health, Inc. (GEM HEALTH), the nationwide virtual specialty care company transforming sleep care, announced today that it has partnered with Sleep Number Corporation (NASDAQ:SNBR) to provide a seamless connection to GEM's virtual sleep care. Users of Sleep Number's newly introduced BreatheIQ can easily connect to GEM SLEEP to start a care j
Snoring can be more than just an annoyance and may indicate underlying health conditions; new technology helps sleepers understand what their snore may mean, offers information about potential health implications, and connects sleepers to a virtual care clinic for potential diagnosis Today, Sleep Number Corporation (NASDAQ:SNBR), a sleep wellness leader, introduced an innovative new app to support the sleep health of millions of snorers. With a free download, BreatheIQ™ allows users to understand what their snore may mean and why breathing irregularities like snoring may matter to their health. Sleep Number already offers smart bed and bases that help to reduce nighttime snoring, such as t
Significant changes enable a smaller, more agile Board structure Sleep Number Corporation (NASDAQ:SNBR) ("Sleep Number") today announced that it has entered into an Agreement (the "Agreement") with Stadium Capital Management, LLC (collectively with its affiliates, "Stadium Capital"), the company's largest shareholder. As part of the Agreement, and combined with other recent announcements, five current members of the Sleep Number Board of Directors (the "Board") will be retiring. As previously announced, Michael J. Harrison and Shelly R. Ibach will not stand for reelection to the Board at the company's 2025 Annual Meeting of Shareholders (the "2025 Annual Meeting"). Pursuant to the Agreeme
Piper Sandler downgraded Sleep Number from Overweight to Neutral and set a new price target of $49.00 from $62.00 previously
Wedbush downgraded Sleep Number from Outperform to Neutral and set a new price target of $54.00 from $80.00 previously
UBS reiterated coverage of Sleep Number with a rating of Neutral and set a new price target of $65.00 from $80.00 previously
4 - Sleep Number Corp (0000827187) (Issuer)
4 - Sleep Number Corp (0000827187) (Issuer)
4 - Sleep Number Corp (0000827187) (Issuer)
4 - Sleep Number Corp (0000827187) (Issuer)
4 - Sleep Number Corp (0000827187) (Issuer)
4 - Sleep Number Corp (0000827187) (Issuer)
8-K - Sleep Number Corp (0000827187) (Filer)
10-K - Sleep Number Corp (0000827187) (Filer)
8-K - Sleep Number Corp (0000827187) (Filer)
Findley has a demonstrated record of accelerating growth and transformation across diverse consumer business models Phillip Eyler to become independent Board Chair, effective after the 2025 Annual Meeting of Shareholders Sleep Number Corporation (NASDAQ:SNBR) today announced that its Board of Directors (the "Board") has appointed Linda Findley as the company's new President and Chief Executive Officer, and as a member of the Board, effective April 7, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250305807579/en/Linda Findley will assume the role of Sleep Number President and CEO on April 7, 2025 (Photo: Business Wire) Fi
Today, Sleep Number Corporation (NASDAQ:SNBR) ("Sleep Number" or the "Company") issued the following statement in response to the public letter to shareholders from Stadium Capital Management, LLC (together with its affiliates, "Stadium"): The Board of Directors (the "Board") and leadership team of Sleep Number welcome shareholder input and suggestions. To that end, we have engaged extensively with Stadium and last November added two directors recommended by Stadium to the Board. Over the last 12 months, members of our Board and leadership team have spoken with Stadium on more than a dozen occasions, and Stadium participated in four meetings with the Board's Capital Allocation and Value E
Calls on Sleep Number to Collaborate with its Largest Shareholder to Add New Directors to the Board, Appoint an Executive Chairman and Ensure a Wholly Independent CEO Search Process to Identify the Company's Next Leader Encourages Shareholders to Make Their Concerns with Sleep Number's Unacceptable Performance and Self-Preservation Tactics Known by Communicating Them to the Company Intends to Nominate Exceptionally Qualified Directors Should the Board Remain Unwilling to Work with Stadium on Changes Necessary to Unlock the Tremendous Value Trapped in Sleep Number's Shares Stadium Capital Management, LLC today sent the below letter to shareholders of Sleep Number Corporation (NASDAQ:SN
Delivered a fourth quarter gross profit rate of 59.9%, up 330 basis points (bp) versus the prior year, with a full-year gross profit rate of 59.6%, up 190 bp versus the prior year Reduced fourth operating expenses by $28 million year-over-year, with an $88 million reduction for full year 2024 (before restructuring costs) Reported a fourth quarter net loss of $5 million compared with a net loss of $25 million for the same period last year Delivered fourth quarter adjusted EBITDA of $26 million, up 43% versus the same period last year, with full year adjusted EBITDA of $120 million which was at the midpoint of our most recent earnings outlook Announced in a separate press release the
Sleep Number Corporation (NASDAQ:SNBR) will release its fiscal fourth quarter and full year results through December 28, 2024, after market close on Wednesday, March 5, 2025. Management will host its regularly scheduled conference call to discuss the company's results at 5 p.m. EST (4 p.m. CST; 2 p.m. PST). To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days. About Sleep Number Corporation Sleep Number is a wellness technology company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our
COMPANY ALSO ANNOUNCES CHAIR, PRESIDENT AND CEO SHELLY IBACH TO RETIRE Reported third quarter net sales of $427 million; delivered adjusted EBITDA of $28 million for the quarter which was consistent with expectations Achieved gross margin rate of 60.8% for the third quarter, up 340 basis points versus last year, ahead of expectations and the highest quarterly gross margin rate since the third quarter of 2021 Reduced operating expenses by $17 million for the third quarter and $60 million year-to-date (before restructuring costs) Increased year-to-date free cash flow by $50 million compared with the same period last year Updated full-year 2024 adjusted EBITDA outlook to a revised ra
SC 13D/A - Sleep Number Corp (0000827187) (Subject)
SC 13D/A - Sleep Number Corp (0000827187) (Subject)
SC 13D/A - Sleep Number Corp (0000827187) (Subject)